The impact of magnesium sulfate on serum magnesium concentrations and intracellular electrolyte concentrations among patients undergoing radio frequency catheter ablation

Connecticut Medicine

Volumn 72, Issue 5, 2008, Pages 261-265

  Shah, Sachin A ^a   Clyne, Christopher A ^a   Henyan, Nickole ^a   Migeed, Mlagdy ^a   Yarlagadda, Ravi ^a   Silver, Burton B ^b   Kluger, Jeffrey ^a   White, C Michael ^a,c  

^a HARTFORD HOSPITAL   (United States)

^b Intracellular Diagnostics Inc   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; MAGNESIUM SULFATE;

ARTICLE; BLOOD; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DOUBLE BLIND PROCEDURE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; TIME;

ATRIAL FIBRILLATION; CATHETER ABLATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; MAGNESIUM SULFATE; MALE; MIDDLE AGED; MOUTH MUCOSA; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 43949083017     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Graber TW: Role of magnesium in health and heart. Comprehens Ther 1987; 13(1)29-35.
2. White CM, Xie J, Chow MSS, Kluger J: Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model. Pharmacother 1999; 19:635-40.
3. Caron MF, Kluger J, Tsikouris JP, et al: Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide. Pharmacother 2003; 23:296-300.
4. Kalus JS, Spencer AP, Tsikouris JP, et al: Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J Health-Syst Pharm 2003; 60:2308-12.
5. McBride BF, Min B, Kluger J, et al: An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Ann Noninv Electrocardiol 2006; 11:163-9.
6. Haigney MCP, Silver B, Tanglao E, et al: Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 1995; 92:2190-7.
7. Haigney MC, Wei S, Kaab S, et al: Loss of cardiac magnesium in experimental heart failure prolongs and destabilizes repolarization in dogs. J Am Coll Cardiol 1998; 31:701-6.
8. Nastou H, Sarros G, Palta M, et al: Fluctuations in serum magnesium levels during total intravenous anaesthesia with propofol. Magnesuim Res 1996; 9:47-53.
9. Okuda T, Kura M, Hatsuoka K, et al: Changes in ionized magnesium concentrations during general anesthesia. Masui Jap J Anesthesiol 1999; 48:136-40.
10. Yago MD, Manas M, Singh J: Intracellular magnesium: Transport and regulation in epithelial secretory cells. Frontiers Biosci 2000; 5:D602-18.